MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q2
hinzugefügt 07.05.2026
Becton, Dickinson and Company Langfristige Verbindlichkeiten 2011-2026 | BDX
Langfristige Verbindlichkeiten Jährlich Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 25 B | 25.7 B | 21.4 B | 13.6 B | 15.3 B | 5.16 B | 4.98 B | 5.25 B | 3.78 B | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 25.7 B | 3.78 B | 13.3 B |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Instrumente
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
1.54 B | $ 60.58 | 0.33 % | $ 12.1 B |  USA |
 |
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M | USA |
 |
iRhythm Technologies
IRTC
|
119 M | $ 115.46 | 1.14 % | $ 3.7 B | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
ICU Medical
ICUI
|
66.7 M | $ 120.37 | -2.13 % | $ 2.97 B | USA |
 |
Repro Med Systems
KRMD
|
239 K | $ 3.87 | -2.76 % | $ 179 M | USA |
 |
Intuitive Surgical
ISRG
|
418 M | $ 421.73 | -1.48 % | $ 151 B | USA |
 |
LeMaitre Vascular
LMAT
|
19.3 M | $ 97.52 | -1.99 % | $ 2.21 B | USA |
 |
Alcon
ALC
|
6.05 B | $ 63.93 | -0.14 % | $ 40.4 B |  Schweiz |
 |
Masimo Corporation
MASI
|
56 M | $ 178.4 | 0.03 % | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
11.2 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.91 B | $ 23.69 | -0.67 % | $ 3.98 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
1.42 M | $ 6.29 | -2.18 % | $ 53.4 K | USA |
 |
Haemonetics Corporation
HAE
|
405 M | $ 56.6 | -0.86 % | $ 2.85 B | USA |
 |
STAAR Surgical Company
STAA
|
12.5 M | $ 32.27 | 0.81 % | $ 1.6 B | USA |
 |
STERIS plc
STE
|
1.53 B | $ 214.08 | -0.88 % | $ 21.1 B | USA |
 |
Teleflex Incorporated
TFX
|
2.77 B | $ 128.92 | -1.04 % | $ 5.75 B | USA |
 |
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
87.4 M | $ 141.43 | -0.52 % | $ 6.85 B | USA |
 |
InfuSystem Holdings
INFU
|
35 M | $ 8.57 | -0.46 % | $ 177 M | USA |
 |
Microbot Medical
MBOT
|
760 K | $ 1.93 | 4.32 % | $ 88.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
1.4 M | $ 0.33 | -1.64 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
626 M | $ 62.4 | -0.26 % | $ 3.69 B | USA |
 |
Utah Medical Products
UTMD
|
5.25 M | $ 63.24 | -0.72 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
427 M | $ 301.39 | 0.4 % | $ 21.8 B | USA |
 |
Pulse Biosciences
PLSE
|
6.72 M | $ 24.12 | -11.01 % | $ 1.63 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 10.04 | -3.6 % | $ 2 B | USA |
 |
Retractable Technologies
RVP
|
2.38 M | $ 0.69 | - | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
9.93 M | $ 59.95 | 2.22 % | $ 197 M | USA |
 |
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
41.7 M | $ 20.55 | -2.42 % | $ 981 M | USA |
 |
Stereotaxis
STXS
|
1.65 M | $ 1.87 | -3.86 % | $ 170 M | USA |
 |
Baxter International
BAX
|
7.05 B | $ 17.32 | -2.64 % | $ 8.89 B | USA |
 |
ResMed
RMD
|
1.05 B | $ 202.53 | -0.01 % | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
261 M | $ 28.37 | 0.79 % | $ 1.35 B | USA |
 |
Harvard Bioscience
HBIO
|
58.5 M | $ 5.36 | -2.9 % | $ 238 M | USA |
 |
NeuroMetrix
NURO
|
917 K | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
148 M | $ 10.88 | -1.36 % | $ 444 M | USA |
 |
Nephros
NEPH
|
1.61 M | $ 3.16 | -5.39 % | $ 33.5 M | USA |
 |
OraSure Technologies
OSUR
|
22.5 M | $ 3.08 | 4.24 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
708 M | $ 105.36 | 1.91 % | $ 5.92 M | USA |